AlphaHunt
Healthcare

AMGN Stock Analysis

Amgen Inc. · current price $339.49 (-0.67% today)

★★★ Average 56/ Alpha Score
Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
LAST EARNINGS Amgen Inc. (AMGN)

Latest earnings

EPS
$6.02 vs $5.28 est · +0.1% vs estimate BEAT
Revenue
$8.62B · -6.1% YoY
Stock reaction (1M)
+4.8%
Beat streak
4 of last 4 quarters

Key metrics

Alpha Score
56/100
Grade
C
Rev Growth YoY
+5.8%
30-day Momentum
+4.8%
Forward P/E
23.7×
Analyst Target
$352.77
Implied Upside
+3.4%

Latest news on AMGN

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA DGX

View all Healthcare stocks →

AMGN — frequently asked

What is AMGN's Alpha Score?

Amgen Inc. (AMGN) currently has a TickerMover Alpha Score of 56/100, rated ★★★ Average. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Amgen Inc. (AMGN) a buy?

TickerMover does not give buy or sell recommendations. AMGN scores 56/100 (★★★ Average) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is AMGN's score updated?

AMGN's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for AMGN →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com